Orchestra Biomed Holdings, Inc. (OBIO) — 8-K Filings

8-K Filings (16)

• 8-K Filing — Nov 13, 2025
• Orchestra BioMed Holdings Files 8-K — Oct 30, 2025 Risk: low
  Orchestra BioMed Holdings, Inc. filed an 8-K on October 30, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, fo
• Orchestra BioMed Files 8-K on Agreements and Equity Sales — Oct 28, 2025 Risk: medium
  Orchestra BioMed Holdings, Inc. filed an 8-K on October 28, 2025, reporting on events as of October 24, 2025. The filing indicates the entry into and terminatio
• Orchestra BioMed Holdings, Inc. Enters Material Definitive Agreement — Aug 4, 2025 Risk: medium
  On July 31, 2025, Orchestra BioMed Holdings, Inc. entered into a Material Definitive Agreement. The company, formerly known as Health Sciences Acquisitions Corp
• Orchestra BioMed Files 8-K with Material Agreements — Jul 31, 2025 Risk: medium
  On July 31, 2025, Orchestra BioMed Holdings, Inc. entered into a material definitive agreement and incurred a direct financial obligation. The company also repo
• Orchestra BioMed Holdings Files 8-K on Shareholder Vote — Jun 24, 2025 Risk: low
  Orchestra BioMed Holdings, Inc. filed an 8-K on June 24, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain spe
• Orchestra BioMed Holdings Files 8-K — Apr 29, 2025 Risk: low
  Orchestra BioMed Holdings, Inc. filed an 8-K on April 29, 2025, reporting on other events and financial statements. The company, formerly known as Health Scienc
• Orchestra BioMed Holdings Files 8-K — Mar 3, 2025 Risk: low
  Orchestra BioMed Holdings, Inc. filed an 8-K on March 3, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly
• Orchestra BioMed Appoints New Chief Medical Officer — Feb 25, 2025 Risk: medium
  Orchestra BioMed Holdings, Inc. announced on February 19, 2025, the appointment of Dr. Jonathan L. R. Roth as Chief Medical Officer. Dr. Roth, previously a Seni
• Orchestra BioMed Holdings Announces Board and Compensation Changes — Feb 5, 2025 Risk: medium
  Orchestra BioMed Holdings, Inc. announced on January 30, 2025, a change in its board of directors and executive compensation arrangements. The filing details th
• Orchestra BioMed Holdings Files 8-K — Aug 12, 2024 Risk: low
  On August 12, 2024, Orchestra BioMed Holdings, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific mater
• Orchestra BioMed Appoints New Chief Medical Officer — Jul 30, 2024 Risk: low
  Orchestra BioMed Holdings, Inc. announced on July 29, 2024, the appointment of Dr. Jonathan L. Weiswasser as Chief Medical Officer. Dr. Weiswasser previously se
• Orchestra BioMed Holdings Files 8-K on Security Holder Vote — Jun 20, 2024 Risk: low
  Orchestra BioMed Holdings, Inc. filed an 8-K on June 20, 2024, to report on the submission of matters to a vote of security holders. The company, formerly known
• Orchestra BioMed Files 8-K — Jun 11, 2024 Risk: low
  Orchestra BioMed Holdings, Inc. filed an 8-K on June 11, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly
• Shockwave Medical to Acquire Orchestra BioMed for $1.5B — Mar 29, 2024 Risk: medium
  Orchestra BioMed Holdings, Inc. announced on March 29, 2024, that it has entered into a definitive agreement to be acquired by Shockwave Medical, Inc. The trans
• Orchestra BioMed Holdings Files 8-K — Mar 7, 2024 Risk: low
  Orchestra BioMed Holdings, Inc. filed an 8-K on March 6, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX